Skip to main content

Advertisement

Log in

Migraine in perimenopausal women

  • CLINICAL ASPECTS OF HEADACHES
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Hormonal changes during the reproductive cycle are thought to account for the variation in migraine occurrence and intensity. Although the majority of women and the specialists treating them do not consider migraine as a component of the climacteric syndrome, many women, in fact, do experience migraine during perimenopause. If a woman already suffers from migraine, the attacks often worsen during menopausal transition. Initial onset of the condition during this period is relatively rare. Women with the premenstrual syndrome (PMS) prior to entering menopause are more likely to experience, during late menopausal transition, an increased prevalence of migraine attacks. Hormone replacement therapy (HRT) can be initiated during the late premenopausal phase and the first years of postmenopause to relieve climacteric symptoms. The effect of HRT on migraine, either as a secondary effect of the therapy or as a preventive measure against perimenopausal migraine, has been variously investigated. HRT preparations should be administered continuously, without intervals, to prevent sudden estrogen deprivation and the migraine attacks that will ensue. Wide varieties of formulations, both systemic and topical, are available. Treatment with transdermal patches and estradiol-based gels is preferable to oral formulations as they maintain constant blood hormone levels. Natural menopause is associated with a lower incidence of migraine as compared with surgical menopause; data on the role of hysterectomy alone or associated with ovariectomy in changing the occurrence of migraine are till now unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harlow SD, Gass M, Hall JE et al (2012) Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97:1159–1168

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Freeman EW, Sammuel MD, Lin H, Gracia CR, Kapoor S (2008) Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 111:127–136

    Article  CAS  PubMed  Google Scholar 

  3. MacGregor EA (2009) Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep 13:399–403

    Article  PubMed  Google Scholar 

  4. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR (1993) Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 17:31–37

    Article  CAS  PubMed  Google Scholar 

  5. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154–2158

    Article  CAS  PubMed  Google Scholar 

  6. Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part 2. Headache 46:365–386

    Article  PubMed  Google Scholar 

  7. Martin VT (2014) Migraine and the menopausal transition. Neurol Sci 35(suppl 1):S65–S69

    Article  Google Scholar 

  8. Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH (2003) Migraine prevalence during menopausal transition. Headache 43:470–478

    Article  PubMed  Google Scholar 

  9. Fettes I (1999) Migraine in the menopause. Neurology 53:S29–S33

    Article  CAS  PubMed  Google Scholar 

  10. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA (2011) Major depression during and after the menopausal transition: study of women’s health across the nation. Psychol Med 41:1879–1888

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Odegard SS, Sand T, Engstrom M, Stovner LJ, Zwart JA, Hagen K (2011) The long-term effect of insomnia on primary headaches: a prospective population-based cohort study (HUNT-2 and HUNT-3). Headache 51:570–580

    Article  PubMed  Google Scholar 

  12. MacGregor EA (1999) Effects of oral and transdermal estrogen replacement on migraine. Cephalagia 19:124–125

    Article  CAS  Google Scholar 

  13. Nappi R, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F (2001) Course of primary headaches during hormone replacement therapy. Maturitas 38:157–163

    Article  CAS  PubMed  Google Scholar 

  14. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67:2159–2163

    Article  CAS  PubMed  Google Scholar 

  15. MacGregor EA (1999) Estrogen replacement and migraine aura. Headache 39:674–678

    Article  CAS  PubMed  Google Scholar 

  16. Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G, Sances G (2002) Hormone supplementation differently affects migraine in postmenopausal women. Headache 42:924–929

    Article  CAS  PubMed  Google Scholar 

  17. Nand SL, Webstel MA, Baber R, Heller GZ (1998) Menopausal symptom side-effects on control and continous estrone sulfate and three doses of medroxyprogesterone acetate. Climacteric 1:211–218

    Article  CAS  PubMed  Google Scholar 

  18. Misakian A, Langer R, Benseor I, Cook N, Manson J, Buring J, Rexrode K (2003) Postmenopausal hormone therapy and migraine headache. J Womens Health 12:1027–1036

    Article  Google Scholar 

  19. Aegidius K, Zwart J, Hagen K, Schei B, Stovner L (2007) Hormone replacement therapy and headache prevalence in post-menopausal women: the head-hunt study. Eur J Neurol 14:73–78

    Article  CAS  PubMed  Google Scholar 

  20. Moorhead T, Hannaford P, Warskyj M (1997) Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gyneacol 104(3):290–297

    Article  CAS  Google Scholar 

  21. Warren JW, Clauw DJ, Wesselmann U, Howard FM, Gallicchio L, Morozov V (2014) Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis. J Psychosomatics Res 77:363–367

    Article  Google Scholar 

  22. MacGregor EA (2012) Perimenopausal migraine in women with vasomotor symptoms. Maturitas 71:79–82

    Article  PubMed  Google Scholar 

  23. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 339:b3914

    Article  PubMed Central  PubMed  Google Scholar 

  24. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S (2010) Migraine headache and ischemic stroke risk: an updated meta-analysis. AMJ 123:612–624

    Article  Google Scholar 

  25. Nappi RE, Sances G, Sommacal A et al (2006) Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 13:818–825

    Article  PubMed  Google Scholar 

  26. Oldenhave A, Jaszmann LJ, Everaerd WT, Haspels AA (1993) Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 168(3 Pt 1):765–771

    Article  CAS  PubMed  Google Scholar 

  27. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC (1993) Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33(7):385–389

    Article  CAS  PubMed  Google Scholar 

  28. Vestergaard P, Hermann AP, Gram J, Jensen LB, Kolthoff N, Abrahamsen B, Brot C, Eiken P (1997) Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 28:137–145

    Article  CAS  PubMed  Google Scholar 

  29. Martin V, Wernke S, Mandell K et al (2003) Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 43:309–321

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors certify that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Allais.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allais, G., Chiarle, G., Bergandi, F. et al. Migraine in perimenopausal women. Neurol Sci 36 (Suppl 1), 79–83 (2015). https://doi.org/10.1007/s10072-015-2155-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2155-8

Keywords

Navigation